share_log

CVS Health | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.3%)

CVS Health | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.3%)

西维斯健康 | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(8.3%)
美股SEC公告 ·  10/24 16:49

Moomoo AI 已提取核心信息

BlackRock, Inc., a major investment management corporation based in Delaware, has filed an amended Schedule 13G with the Securities and Exchange Commission on September 30, 2024, indicating a significant ownership stake in CVS Health Corporation. The filing reveals that BlackRock now beneficially owns 104,561,659 shares of CVS Health, which represents 8.3% of the company's common stock. This position gives BlackRock sole voting power over 93,976,550 shares and sole dispositive power over the entire 104,561,659 shares held. The filing underscores BlackRock's status as a parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G). The address of CVS Health's principal executive offices is listed as One CVS Drive, Woonsocket, RI 02895. The filing also includes a list of entities under BlackRock's umbrella that beneficially own 5% or greater of the outstanding shares of CVS Health's common stock class. The document was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., on October 24, 2024.
BlackRock, Inc., a major investment management corporation based in Delaware, has filed an amended Schedule 13G with the Securities and Exchange Commission on September 30, 2024, indicating a significant ownership stake in CVS Health Corporation. The filing reveals that BlackRock now beneficially owns 104,561,659 shares of CVS Health, which represents 8.3% of the company's common stock. This position gives BlackRock sole voting power over 93,976,550 shares and sole dispositive power over the entire 104,561,659 shares held. The filing underscores BlackRock's status as a parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G). The address of CVS Health's principal executive offices is listed as One CVS Drive, Woonsocket, RI 02895. The filing also includes a list of entities under BlackRock's umbrella that beneficially own 5% or greater of the outstanding shares of CVS Health's common stock class. The document was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., on October 24, 2024.
贝莱德,一家总部位于特拉华州的主要投资管理公司,于2024年9月30日向证券交易委员会提交了修订后的13G表,显示其在西维斯健康公司拥有重要股权。申报文件显示,贝莱德目前有利益拥有西维斯健康公司的104,561,659股股份,占公司普通股的8.3%。该头寸使贝莱德对93,976,550股股份拥有唯一的表决权,并对持有的整个104,561,659股股份拥有单独的处置权。该申报强调了贝莱德作为母公司或控制人的地位,符合规则13d-1(b)(1)(ii)(G)的规定。西维斯健康公司的主要执行办公室地址列为One CVS Drive, Woonsocket, RI 02895。该申报还包括一份在贝莱德旗下受益拥有西维斯健康公司普通股类股份的5%或更多的实体名单。文件由贝莱德公司的代理人Spencer Fleming于2024年10月24日签署。
贝莱德,一家总部位于特拉华州的主要投资管理公司,于2024年9月30日向证券交易委员会提交了修订后的13G表,显示其在西维斯健康公司拥有重要股权。申报文件显示,贝莱德目前有利益拥有西维斯健康公司的104,561,659股股份,占公司普通股的8.3%。该头寸使贝莱德对93,976,550股股份拥有唯一的表决权,并对持有的整个104,561,659股股份拥有单独的处置权。该申报强调了贝莱德作为母公司或控制人的地位,符合规则13d-1(b)(1)(ii)(G)的规定。西维斯健康公司的主要执行办公室地址列为One CVS Drive, Woonsocket, RI 02895。该申报还包括一份在贝莱德旗下受益拥有西维斯健康公司普通股类股份的5%或更多的实体名单。文件由贝莱德公司的代理人Spencer Fleming于2024年10月24日签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息